Transient hypophysitis after cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade.
Shaw
Stephanie A
SA
FAAP, FACE, Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Unit 435, Houston, Texas 77030, USA.
Camacho
Luis H
LH
McCutcheon
Ian E
IE
Waguespack
Steven G
SG
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology*; D000943:Antigens, Differentiation / Q000276:immunology*; D060908:CTLA-4 Antigen; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D010900:Pituitary Diseases / Q000175:diagnosis* / Q000473:pathology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human